Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government what was the total number of (1) Oxford/AstraZeneca, and (2) Pfizer/BioNTech, COVID-19 vaccine vials allocated to the UK held in stock in each month in (a) 2019, and (b) 2020.

We have been monitoring the requirements across the supply chain from supplier through to patient for some time. There are clear supply chain plans in place for both the supply and onward deployment of all vaccine candidates. This includes materials, manufacturing, transportation, storage and distribution.

Vaccines and vials are a precious resource in very high demand across the world and therefore for security reasons it is not possible to provide detail about the size of our supplies and exact detail about future deliveries. It should be noted that the UK has a sufficient number of glass vials available, due to orders already placed.